>>> US Research Calls I

Research Calls I
  • Upgrades
    • FedEx (FDX) upgraded to Outperform from Underperform at BNP Paribas Exane, tgt $270
    • Huntington Bancshares (HBAN) upgraded to Outperform from Peer Perform at Wolfe Research, tgt $21
    • Meta Platforms (META) upgraded to Hold from Underperform at Needham
    • UPS (UPS) upgraded to Neutral from Underperform at BNP Paribas Exane; tgt $100
    • Valley National (VLY) upgraded to Overweight from Equal Weight at Morgan Stanley, tgt $11
  • Downgrades
    • NV5 Global (NVEE) downgraded to Hold from Buy at Maxim Group
    • PNC Financial (PNC) downgraded to Peer Perform from Outperform at Wolfe Research
    • Rio Tinto (RIO) downgraded to Hold from Buy at Berenberg
    • Theratechnologies (THTX) downgraded to Hold from Buy at JonesResearch
    • Two Harbors (TWO) downgraded to Market Perform from Outperform at Citizens JMP
  • Others
    • Absci (ABSI) assumed with an Overweight at Morgan Stanley, tgt $7
    • Argenx (ARGX) assumed with an Overweight at Morgan Stanley, tgt $700
    • Ascendis Pharma (ASND) assumed with an Overweight at Morgan Stanley, tgt $250
    • Axsome Therapeutics (AXSM) assumed with an Overweight at Morgan Stanley, tgt $190
    • BioMarin Pharmaceutical (BMRN) resumed with an Overweight at Morgan Stanley; tgt $97
    • Certara (CERT) resumed with an Equal-Weight at Morgan Stanley; tgt $16
    • Disc Medicine (IRON) resumed with an Overweight at Morgan Stanley; tgt $85
    • Kymera Therapeutics (KYMR) assumed with an Overweight at Morgan Stanley, tgt $70
    • Prairie Operating (PROP) initiated with a Sector Weight at KeyBanc
    • Primoris Services (PRIM) initiated with a Buy at Janney
    • Ralliant (RAL) initiated with an Underperform at BofA Securities, tgt $48
    • Recursion Pharmaceuticals (RXRX) assumed with an Equal Weight at Morgan Stanley, tgt $5
    • Sana Biotechnology (SANA) assumed with an Overweight at Morgan Stanley, tgt $12
    • Schrodinger (SDGR) assumed with an Equal Weight at Morgan Stanley, tgt $28
    • Telix Pharmaceuticals (TLX) initiated with a Buy at H.C. Wainwright, tgt $23